Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Am J Respir Crit Care Med ; 176(1): 70-7, 2007 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-17363774

RESUMEN

RATIONALE: Hard metal lung disease is caused by exposure to hard metal, a synthetic compound that combines tungsten carbide with cobalt as well as a number of other metals. Interstitial lung disease caused by hard metal is uniquely characterized by giant cell interstitial pneumonia. The pathogenesis of hard metal lung disease is unclear. OBJECTIVES: To elucidate the distribution of inhaled hard metal and reactive inflammatory cells in biopsy lung tissue from patients with hard metal lung disease. METHODS: Seventeen patients with interstitial lung disease in which tungsten was detected and five control subjects were studied. Detection and mapping of elements were performed with an electron probe microanalyzer equipped with a wavelength dispersive spectrometer. We immunohistochemically stained mononuclear cells, in tissue samples available from five patients, with anti-human CD4, CD8, CD20, CD68, and CD163 antibodies, and compared the distribution of positive cells with hard metal elements. MEASUREMENTS AND MAIN RESULTS: Thirteen of 17 patients were pathologically diagnosed as having giant cell interstitial pneumonia. Tungsten and cobalt were accumulated in the centrilobular fibrotic lesions, but were never found in the control lungs. CD8+ lymphocytes and CD163+ monocyte-macrophages were distributed predominantly in centrilobular fibrotic lesions around the hard metal elements. CD163+ colocalized with tungsten. Small numbers of CD8+ and CD163+ cells were also immunohistochemically shown in peribronchiolar areas and alveolar walls. CONCLUSIONS: Macrophages may phagocytose inhaled tungsten via CD163 and play an important role in forming the fibrotic lesion of hard metal lung disease with cytotoxic T lymphocytes.


Asunto(s)
Antígenos CD/inmunología , Antígenos de Diferenciación Mielomonocítica/inmunología , Linfocitos T CD8-positivos/inmunología , Cobalto/inmunología , Células Gigantes de Cuerpo Extraño , Enfermedades Pulmonares Intersticiales , Macrófagos Alveolares/inmunología , Receptores de Superficie Celular/inmunología , Tungsteno/inmunología , Adulto , Aleaciones/efectos adversos , Biopsia , Estudios de Casos y Controles , Cobalto/efectos adversos , Estudios de Cohortes , Femenino , Células Gigantes de Cuerpo Extraño/inmunología , Células Gigantes de Cuerpo Extraño/patología , Humanos , Inmunohistoquímica , Enfermedades Pulmonares Intersticiales/inmunología , Enfermedades Pulmonares Intersticiales/patología , Macrófagos Alveolares/patología , Masculino , Persona de Mediana Edad , Exposición Profesional , Fagocitosis/inmunología , Linfocitos T Citotóxicos/inmunología , Tungsteno/efectos adversos , Compuestos de Tungsteno/efectos adversos , Compuestos de Tungsteno/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA